223 related articles for article (PubMed ID: 25872564)
61. Oxaliplatin: a new drug for the treatment of metastatic carcinoma of the colon or rectum.
Baker DE
Rev Gastroenterol Disord; 2003; 3(1):31-8. PubMed ID: 12684591
[TBL] [Abstract][Full Text] [Related]
62. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
Gammon D; Bhargava P; McCormick MJ
Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
[TBL] [Abstract][Full Text] [Related]
63. Anaphylaxis produced by oxaliplatin.
González-Mahave I; Lobera Iabairu T; Blasco Sarramián A; del Pozo Gil MD; Zorrilla M; Vélez de Mendizábal E
J Investig Allergol Clin Immunol; 2005; 15(1):75-7. PubMed ID: 15864887
[TBL] [Abstract][Full Text] [Related]
64. Oxaliplatin toxicity presenting as a liver nodule - case report.
Alexandrino H; Oliveira D; Cipriano MA; Ferreira L; Tralhão JG; Castro E Sousa F
BMC Cancer; 2015 Apr; 15():247. PubMed ID: 25886004
[TBL] [Abstract][Full Text] [Related]
65. Delayed urticaria with oxaliplatin.
Villée C; Tennstedt D; Marot L; Goossens A; Baeck M
Contact Dermatitis; 2010 Jul; 63(1):50-3. PubMed ID: 20597935
[No Abstract] [Full Text] [Related]
66. Atypical presentation of acute neurotoxicity secondary to oxaliplatin.
Uña E
J Oncol Pharm Pract; 2010 Dec; 16(4):280-2. PubMed ID: 20015928
[TBL] [Abstract][Full Text] [Related]
67. Oxaliplatin-related side effects: characteristics and management.
Cassidy J; Misset JL
Semin Oncol; 2002 Oct; 29(5 Suppl 15):11-20. PubMed ID: 12422304
[TBL] [Abstract][Full Text] [Related]
68. Acute hemolysis after receiving oxaliplatin treatment: a case report and literature review.
Lai JI; Wang WS
Pharm World Sci; 2009 Oct; 31(5):538-541. PubMed ID: 19588266
[TBL] [Abstract][Full Text] [Related]
69. Sudden sensorineural hearing loss secondary to metronidazole ototoxicity.
Rotman A; Michael P; Tykocinski M; O'Leary SJ
Med J Aust; 2015 Sep; 203(6):253-253e.1. PubMed ID: 26377290
[No Abstract] [Full Text] [Related]
70. [Molecular Mechanisms of Taste Disorder in Oxaliplatin-administered Rats].
Nishida K
Yakugaku Zasshi; 2016; 136(7):1017-21. PubMed ID: 27374965
[TBL] [Abstract][Full Text] [Related]
71. Vesicant characteristics of oxaliplatin following antecubital extravasation.
Kennedy JG; Donahue JP; Hoang B; Boland PJ
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):237-9. PubMed ID: 12924452
[TBL] [Abstract][Full Text] [Related]
72. Severe respiratory symptoms to oxaliplatin infusion: a case report of delayed hypersensitivity reaction.
Potenza S; Nasti G; Ottaiano A; Filippelli A; Rossi F; Capuano A
Invest New Drugs; 2010 Apr; 28(2):185-6. PubMed ID: 19352593
[TBL] [Abstract][Full Text] [Related]
73. Rare Case of Sudden Bilateral Sensorineural Hearing Loss After Cocaine Abuse.
Patell K; Al Armashi AR; Somoza-Cano FJ; Polanco VP; Ravakhah K
Am J Ther; 2021 Jul; 29(1):e137-e139. PubMed ID: 34264891
[No Abstract] [Full Text] [Related]
74. Anaphylaxis after oxaliplatin.
Médioni J; Coulon MA; Morere JF; Hennebelle F; Piperno-Neumann S; Breau JL
Ann Oncol; 1999 May; 10(5):610. PubMed ID: 10416017
[No Abstract] [Full Text] [Related]
75. A case of acute tubular necrosis due to oxaliplatin.
Pinotti G; Martinelli B
Ann Oncol; 2002 Dec; 13(12):1951-2. PubMed ID: 12453866
[No Abstract] [Full Text] [Related]
76. Renal tubular acidosis due to oxaliplatin.
Linch M; Cunningham D; Mingo O; Stiles A; Farquhar-Smith WP
Ann Oncol; 2007 Apr; 18(4):805-6. PubMed ID: 17389529
[No Abstract] [Full Text] [Related]
77. A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance.
Basso M; Cassano A; Modoni A; Spada D; Trigila N; Quirino M; Schinzari G; Barone C
Eur J Clin Pharmacol; 2008 Jul; 64(7):739-41. PubMed ID: 18350285
[No Abstract] [Full Text] [Related]
78. Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer.
Romano A; Capozza MA; Mastrangelo S; Maurizi P; Triarico S; Rolesi R; Attinà G; Fetoni AR; Ruggiero A
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32429551
[TBL] [Abstract][Full Text] [Related]
79. Acute cochleovestibular toxicity due to topical application of potassium iodide.
Boudewyns A; Claes J
Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):109-11. PubMed ID: 11374249
[TBL] [Abstract][Full Text] [Related]
80. Motor "freezing" with oxaliplatin.
Patel MA; McDevitt RL; Sassack W; Zalupski MM
J Oncol Pharm Pract; 2021 Dec; 27(8):2014-2017. PubMed ID: 33765873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
